JPRN-UMIN000044754
Not yet recruiting
Phase 1
Phase I clinical trial to examine the safety of stereotactic radiotherapy including subclinical regions for pancreatic cancer - Clinical trial of stereotactic radiotherapy including subclinical regions for pancreatic cancer
ConditionsPancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- Tohoku University
- Enrollment
- 18
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) A metallic stent has been inserted in the bile duct and duodenum. (2\) Peritoneal dissemination has been confirmed by peritoneal cytology within 4 weeks prior to enrollment. (3\) Cases with severe complication such as heart disease, renal disease, and hepatic disease (4\) Fever over 38 degrees Celsius (5\) Other active malignancy at the start of our study (6\) Patients requiring systemic steroids medication or other immunosuppressants (7\) Patients who can' t receive neither iodic drug nor gadolinium because of drug allergy (8\) Cases with severe psychological disorder (9\) Other cases that were judged to be inappropriate for conducting this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Clinical trial to verify safety and efficacy of Stemirac that does not meet in-process control specifications and shipping specifications for acute traumatic spinal cord injury patients.JPRN-jRCT2013210056Tomii Ryo10
Completed
Phase 1
A trial to test the safety of a herbal formulatioCTRI/2018/02/011689SK Biolabs100
Completed
Phase 1
A trial to test the safety of a herbal drug.CTRI/2017/11/010617SK Biolabs100
Completed
Phase 1
A clinical trial to test the safety of a drugCTRI/2017/11/010540SK Biolabs100
Completed
Phase 1
A trial to test the safety of a drugCTRI/2017/12/010788SK Biolabs100